• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何用去氨加压素治疗出血性疾病?

How do you treat bleeding disorders with desmopressin?

作者信息

Ozgönenel Bülent, Rajpurkar Madhvi, Lusher Jeanne M

机构信息

Carman and Ann Adam's Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan 48201-2196, USA.

出版信息

Postgrad Med J. 2007 Mar;83(977):159-63. doi: 10.1136/pgmj.2006.052118.

DOI:10.1136/pgmj.2006.052118
PMID:17344569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2599976/
Abstract

Desmopressin is an analog of vasopressin that exerts a substantial haemostatic effect by inducing the release of von Willebrand factor from its storage sites in endothelial cells. It has proved useful in treating or preventing bleeding episodes in patients with von Willebrand disease, haemophilia A and platelet function defects. Its efficacy in achieving a satisfactory level of haemostasis has reduced the use of blood products to treat bleeding episodes. Clinicians need to become familiar with the use of this drug that has become a home medication for many patients with inherited bleeding disorders.

摘要

去氨加压素是血管加压素的类似物,通过诱导血管性血友病因子从内皮细胞储存部位释放而发挥显著的止血作用。已证明它在治疗或预防血管性血友病、甲型血友病和血小板功能缺陷患者的出血发作方面有用。其在实现满意止血水平方面的疗效减少了用于治疗出血发作的血液制品的使用。临床医生需要熟悉这种已成为许多遗传性出血性疾病患者家庭用药的药物的使用。

相似文献

1
How do you treat bleeding disorders with desmopressin?如何用去氨加压素治疗出血性疾病?
Postgrad Med J. 2007 Mar;83(977):159-63. doi: 10.1136/pgmj.2006.052118.
2
Desmopressin in the treatment of women's bleeding disorders.去氨加压素在女性出血性疾病治疗中的应用
Haemophilia. 1999 Jul;5(4):233-7. doi: 10.1046/j.1365-2516.1999.00313.x.
3
Desmopressin (DDAVP) and hemostasis.去氨加压素(DDAVP)与止血
Ann Hematol. 1994 Oct;69(4):173-80. doi: 10.1007/BF02215950.
4
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.抗血管性血友病因子适体 ARC1779 治疗 2b 型血管性血友病随机先导试验
Thromb Haemost. 2010 Sep;104(3):563-70. doi: 10.1160/TH10-01-0027. Epub 2010 Jun 29.
5
Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.去氨加压素对先天性出血性疾病患儿止血作用的评估。
Haemophilia. 2008 May;14(3):524-30. doi: 10.1111/j.1365-2516.2008.01672.x. Epub 2008 Feb 18.
6
Desmopressin (dDAVP): a powerful general hemostatic agent?去氨加压素(dDAVP):一种强效的通用止血剂?
Nouv Rev Fr Hematol (1978). 1989;31(2):163-5.
7
Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
Semin Thromb Hemost. 2005;31(4):441-8. doi: 10.1055/s-2005-916679.
8
Desmopressin--a nontransfusional form of prevention of postextractive bleeding in some patients with von Willebrand's type I disease. Case report.去氨加压素——一种预防部分Ⅰ型血管性血友病患者拔牙后出血的非输血方式。病例报告。
Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):150-3.
9
The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor.去氨加压素对服用替格瑞洛的健康志愿者出血时间和血小板聚集的影响。
J Clin Pharm Ther. 2014 Apr;39(2):186-91. doi: 10.1111/jcpt.12130. Epub 2014 Jan 21.
10
Common management issues in pediatric patients with mild bleeding disorders.小儿轻度出血性疾病的常见管理问题。
Semin Thromb Hemost. 2012 Oct;38(7):720-6. doi: 10.1055/s-0032-1326787. Epub 2012 Oct 3.

引用本文的文献

1
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding.去氨加压素治疗肾活检后出血的随机双盲安慰剂对照试验
Kidney Int Rep. 2025 Apr 17;10(7):2436-2445. doi: 10.1016/j.ekir.2025.04.019. eCollection 2025 Jul.
2
Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025.JAK2 变异型原发性血小板增多症的出血并发症:2025 年的再探讨
EJHaem. 2025 Jul 4;6(4):e70088. doi: 10.1002/jha2.70088. eCollection 2025 Aug.
3
Preoperative Desmopressin for Bleeding Reduction During Rhinoplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.鼻整形术中用于减少出血的术前去氨加压素:随机对照试验的系统评价和荟萃分析
Aesthetic Plast Surg. 2025 Jun 2. doi: 10.1007/s00266-025-04916-7.
4
When our intuition lets us down-something believed to be beneficial may actually be harmful.当我们的直觉误导我们时,一些被认为有益的东西可能实际上是有害的。
Can J Anaesth. 2025 Apr;72(4):525-528. doi: 10.1007/s12630-025-02929-z. Epub 2025 Mar 21.
5
Recurrent Symptomatic Severe Hyponatremia in Craniopharyngioma.颅咽管瘤复发性症状性严重低钠血症
Cureus. 2025 Feb 16;17(2):e79110. doi: 10.7759/cureus.79110. eCollection 2025 Feb.
6
[Effects of desmopressin versus tranexamic acid on reducing bleeding in knee arthroplasty: a double-blind randomized study].去氨加压素与氨甲环酸对减少膝关节置换术中出血的效果:一项双盲随机研究
Pan Afr Med J. 2024 Nov 7;49:67. doi: 10.11604/pamj.2024.49.67.43551. eCollection 2024.
7
Hemostats in the clinic.临床中的止血钳。
Bioeng Transl Med. 2024 May 1;9(6):e10673. doi: 10.1002/btm2.10673. eCollection 2024 Nov.
8
Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis.去氨加压素在心脏大手术中的应用与肾功能损害有关:一项回顾性单中心分析。
BMC Anesthesiol. 2024 Oct 7;24(1):357. doi: 10.1186/s12871-024-02680-w.
9
Role of Desmopressin Acetate before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Kidney Dysfunction.醋酸去氨加压素在肾功能不全患者经皮超声引导下肾活检前的作用
Indian J Nephrol. 2024 May-Jun;34(3):228-232. doi: 10.4103/ijn.ijn_34_23. Epub 2023 Sep 29.
10
Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.病例报告:围手术期使用羟基脲有助于减少与获得性血管性血友病综合征相关的原发性血小板增多症患者的出血。
Front Oncol. 2024 Feb 1;14:1326209. doi: 10.3389/fonc.2024.1326209. eCollection 2024.

本文引用的文献

1
Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature.血管性血友病患者的动脉和静脉血栓形成:文献综述
J Thromb Thrombolysis. 2006 Apr;21(2):175-8. doi: 10.1007/s11239-006-5732-0.
2
Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study.口服避孕药与去氨加压素鼻腔喷雾剂:治疗血管性血友病相关性月经过多的使用模式:一项单机构研究
J Pediatr Hematol Oncol. 2005 Jul;27(7):357-63. doi: 10.1097/01.mph.0000173175.95152.95.
3
The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.血小板功能分析仪-100检测在儿童和成人止血缺陷的调查及管理中的作用。
Br J Haematol. 2005 Jul;130(1):3-10. doi: 10.1111/j.1365-2141.2005.05511.x.
4
von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management.血管性血友病与月经过多:患病率、诊断及管理
Am J Hematol. 2005 Jul;79(3):220-8. doi: 10.1002/ajh.20372.
5
DDAVP-induced hyponatremia in young children.
J Pediatr Hematol Oncol. 2005 Jun;27(6):330-2. doi: 10.1097/01.mph.0000168728.49519.4a.
6
ADAMTS13 turns 3.ADAMTS13问世三周年。
Blood. 2005 Jul 1;106(1):11-7. doi: 10.1182/blood-2004-10-4097. Epub 2005 Mar 17.
7
von Willebrand disease and women's health.血管性血友病与女性健康。
Semin Hematol. 2005 Jan;42(1):42-8. doi: 10.1053/j.seminhematol.2004.11.002.
8
Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration.
Thromb Haemost. 2004 Oct;92(4):886-7.
9
Treatment of von Willebrand's Disease.血管性血友病的治疗
N Engl J Med. 2004 Aug 12;351(7):683-94. doi: 10.1056/NEJMra040403.
10
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.重度1型和2型血管性血友病患者对去氨加压素的生物学反应:一项欧洲多中心研究结果
Blood. 2004 Mar 15;103(6):2032-8. doi: 10.1182/blood-2003-06-2072. Epub 2003 Nov 20.